Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

ClinicalTrials.gov ID: NCT05433584

Public ClinicalTrials.gov record NCT05433584. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing treatment options when treatment is initiated early.

Study identification

NCT ID
NCT05433584
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
780 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2022 (Actual)
Primary completion
Oct 21, 2025 (Actual)
Completion
Nov 2027 (Estimated)
Last update posted
Dec 12, 2025

2022 – 2027

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Cahaba Research - Trussville Birmingham Alabama 35235 —
San Fernando Valley Health Institute Canoga Park California 91304 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255 —
Velocity Clinical Research, San Diego La Mesa California 91942 —
Clinical Trials Research Lincoln California 95648 —
Velocity Clinical Research, Westlake Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Velocity Clinical Research, North Hollywood North Hollywood California 91606 —
Velocity Clinical Research, Panorama City Panorama City California 91402 —
Western University of Health Sciences Pomona California 91766 —
Velocity Clinical Research, Santa Ana Santa Ana California 92704 —
New England Research Associates, LLC Bridgeport Connecticut 06606 —
Excel Medical Clinical Trials Boca Raton Florida 33434 —
Alliance for Multispecialty Research, LLC Coral Gables Florida 33134 —
South Florida Clinical Research Institute Margate Florida 33063 —
Emory University School of Medicine- Grady Campus Atlanta Georgia 30303 —
Center for Advanced Research & Education Gainesville Georgia 30501 —
Qualmedica Research, LLC Evansville Indiana 47715 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Qualmedica Research Bowling Green Kentucky 42101 —
NECCR PrimaCare Research Fall River Massachusetts 02721 —
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Clinvest Research LLC Springfield Missouri 65807 —
Research Foundation of SUNY - University of Buffalo Buffalo New York 14221 —
Lucas Research, Inc Morehead City North Carolina 28557 —
The Corvallis Clinic, P.C. Corvallis Oregon 97330 —
Clinical Research of Philadelphia Philadelphia Pennsylvania 19114 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
Velocity Clinical Research, Spartanburg Spartanburg South Carolina 29303 —
Dallas Diabetes Research Center Dallas Texas 75230 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05433584, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2025 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05433584 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →